Remicade

Merck Discounts Remicade by 25% in U.K. to Fend Off Rivals
Bloomberg
Fri, 10/23/15 - 09:20 am
Merck
Remicade
UK
drug discounts
rheumatoid arthritis
AbbVie And Amgen Threatened By Biosimilars
Bidness, ETC
Mon, 08/17/15 - 07:57 am
AbbVie
Amgen
biosimilars
JNJ
Sandoz
Novartis
Humira
Neupogen
Remicade
Nuelasta
Enbrel
epoetin-alfa
The Top Drug Launches Of All Time
Forbes
Wed, 08/5/15 - 08:04 am
Sovaldi
Lipitor
Humira
Plavix
Advair
Remicade
Enbrel
Prilosec
J&J prepares to defend Remicade market share
Medical Marketing and Media
Tue, 07/14/15 - 10:34 pm
JNJ
Remicade
biosimilars
Alex Gorsky
Big deal for biosims? Major French hospital group opts for Hospira's Remicade copy
BioPharma Dive
Mon, 07/6/15 - 12:07 pm
biosimilars
France
Hospira
Remicade
Biosim war heats up as Merck's Remicade & Enbrel biosimilars bag major wins in RA
BioPharma Dive
Wed, 06/10/15 - 11:10 am
Merck
Remicade
Enbrel
biosimilars
rheumatoid arthritis
Drug switch study bolsters case for copies of biotech medicine
Yahoo/Reuters
Wed, 06/10/15 - 09:10 am
biosimilars
Merck
JNJ
Remicade
J&J's 2018 Remicade patent smacked down at PTO again
Fierce Pharma
Fri, 05/1/15 - 08:54 am
JNJ
Remicade
patents
PTO
Bullied in Norway, Merck Sees Sales of Blockbuster Dive
Bloomberg
Thu, 04/23/15 - 03:22 am
Merck
rheumatoid arthritis
Norway
Europe
Remicade
Biogen Goes Generic
Investopedia
Fri, 04/10/15 - 10:12 am
Biogen
generics
Rituxan
anti-TNF
SB4
biosimilars
Remicade
SB2
Enbrel
Celltrion eyes biosim Remicade launch in the U.S. this year
Fierce Pharma Marketing
Wed, 04/1/15 - 11:14 am
Celltrion
biosimilars
Remicade
Merck touts a bright future in biosimilars with a stable of would-be blockbusters
Fierce Biotech
Wed, 03/4/15 - 09:51 am
Merck
biosimilars
AbbVie
Humira
JNJ
Remicade
Amgen
Enbrel
Samsung Bioepis
Biogen Idec
FDA postpones key hearing on biosimilar copy of blockbuster drug
Yahoo/Reuters
Thu, 02/26/15 - 09:55 am
FDA
biosimilars
Rensima
Remicade
JNJ
rheumatoid arthritis
Crohn's Disease
Hospira
Celltrion
Celltrion, Hospira avoid biosimilar traffic jam in U.S.
BioCentury
Tue, 02/24/15 - 10:36 am
Celltrion
Hospira
biosimilars
Remicade
FirstWord Lists – The best selling drugs in 2014
First Word Pharma
Mon, 02/16/15 - 04:50 pm
Humira
Sovaldi
Remicade
Enbrel
Lantus
Rituxan
Advair
Avastin
Herceptin
Januvia
Merck
AbbVie
Gilead Sciences
JNJ
Amgen
Pfizer
Sanofi
Roche
GSK
Johnson & Johnson Faces Pressure From U.S. Patent Office
Yahoo/Benzinga
Sat, 02/14/15 - 10:36 am
JNJ
patents
Remicade
Competition to J&J's Remicade looms in U.S. as biosimilar conquers new markets
Fierce Biotech
Wed, 02/11/15 - 08:57 am
JNJ
Remicade
biosimilars
FDA
Celltrion
Remsima
Abandonment rates indicate room in the anti-TNF market
Medical Marketing and Media
Fri, 01/16/15 - 08:52 am
anti-TNF
JNJ
Remicade
Humira
AbbVie
Biogen Idec
Most Popular News Headlines For Monday, August 11 2014
CP Wire
Tue, 08/12/14 - 09:13 am
Celltrion
Remsima
Jannsen
Remicade
Invokamet
JNJ
Sanofi
Cologuard
MannKind
Afrezza
EXACT Sciences
Most popular news headlines for Monday, August 11 2014
Tue, 08/12/14 - 09:07 am
Celltrion
Remsima
Jannsen
Remicade
Invokamet
JNJ
Sanofi
Cologuard
MannKind
Afrezza
EXACT Sciences

Pages